Effectiveness of bevacizumab exposure beyond disease progression in patients with non-small-cell lung cancer: analyses of the ARIES observational cohort study

导出原文传递

翻译打印收藏纠错

作者： Leon, Larry ^[1] ; Kosty, Michael ^[2] ; Jahanzeb, Mohammad ^[3] ; Spigel, David ^[4] ; Wozniak, Antoinette J. ^[5] ; Brahmer, Julie ^[6] ; Fish, Susan ^[7] ; Flick, E. Dawn ; Hazard, Sebastien J. ; Lynch, Thomas J.

作者单位： Scripps Clin, Dept Oncol, La Jolla, CA 92037 USA ^[1] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI USA ^[2] Genentech Inc, Dept US Med Affairs, 1 DNA Way, San Francisco, CA 94080 USA ^[3] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA ^[4] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Internal Med, Miami, FL USA ^[5] Sarah Cannon Res Inst, Dept Oncol, Nashville, TN USA ^[6] Yale Canc Ctr, Dept Oncol, New Haven, CT USA ^[7]

关键词 bevacizumab non-small-cell lung cancer observational cohort study treatment beyond progression pharmacoepidemiology

发布时间 2017-08-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交